東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ null ]

切換: 標籤 | MARC模式 | ISBD

Peptide Therapeutics and Diagnostics...

Faucher, Franco Fernando,

FindBook

Google Book

Amazon

博客來

Peptide Therapeutics and Diagnostics for Cancer Therapy and Imaging /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Peptide Therapeutics and Diagnostics for Cancer Therapy and Imaging // Franco Fernando Faucher.
作者:	Faucher, Franco Fernando,
面頁冊數:	1 electronic resource (441 pages)
附註:	Source: Dissertations Abstracts International, Volume: 86-05, Section: B.
Contained By:	Dissertations Abstracts International86-05B.
標題:	Infections. -
電子資源:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31643297
ISBN:	9798346382188

Peptide Therapeutics and Diagnostics for Cancer Therapy and Imaging /
Faucher, Franco Fernando,

Peptide Therapeutics and Diagnostics for Cancer Therapy and Imaging /Franco Fernando Faucher. - 1 electronic resource (441 pages)

Source: Dissertations Abstracts International, Volume: 86-05, Section: B.

Peptides have long been part of the drug development pipeline. Therefore, by further exploring the inherent benefits and weaknesses of this modality, we can better design next generation therapeutics and diagnostics. Peptides are generally defined as amino acid polymers comprised of between 2-50 amino acids, making them distinct from small molecules(50 amino acids). Peptides are made of both natural and unnatural amino acid fragments; this modularity has allowed drug designers to generate highly specific therapeutics as many derivatives can be quickly designed to tightly engage the target of interest. Furthermore, the simplicity of their modular design from largely naturally occurring functional groups has allowed drug designers to logically and efficiently modulate properties such as pharmacokinetics, pharmacodynamics, and safety. Due to the natural affinity of peptide like substrates for the active site of proteases, peptides have traditionally been used to target serine hydrolases which play important roles in the pathogenesis of many infectious diseases and cancers. Chapter 1 of this thesis provides a review of recent approaches to use selective covalent inhibitors of serine hydrolases to develop activity-based probes (ABPs). This includes new methodologies that have been designed to improve the potency and specificity of ABPs and to expand their scope and usage as clinically relevant imaging agents. Chapter 2, describes the development of ratiometric activity-based optical contrast agents for image guided surgery. This work addresses many of the current limitations of current clinical contrast agents and demonstrates that peptide-based probes are effective as diagnostic imaging agents. Chapter 3 outlines the use of polymers as scaffolds for improving the in vivoproperties of peptide based imaging contrast agents. These findings provide new insights into the use of polymer-based backbones for enhancing the pharmacodynamic and pharmacokinetic properties of peptide drugs. Chapter 4 outlines a synthesis method for generating diverse covalent cyclic peptides. These peptides are used to identify new druggable targets with the hopes of expanding the druggable proteome. These works, as a collective, are specific applications of peptide-based molecules in the setting of cancer pathologies. Together these works show that peptides can elucidate biological function, such as the case of generating cancer specific fluorescent signals. Furthermore the inhibitor discovery with fluorosulfates shows that peptides can modulate biological systems and can be engineered to create novel functions. Overall, this work provides further evidence for the continued exploration of peptide therapeutics and diagnostics in the context of cancer therapy and imaging.

English

ISBN: 9798346382188Subjects--Topical Terms:

1621997
Infections.

Peptide Therapeutics and Diagnostics for Cancer Therapy and Imaging /
LDR:04149nmm a22004093i 4500 001 2432464
005 20250707081508.5
006 m o d
007 cr|nu||||||||
008 261011s2024 miu||||||m |||||||eng d
020 $a 9798346382188
035 $a (MiAaPQD)AAI31643297
035 $a (MiAaPQD)Stanforddj070hs6360
035 $a AAI31643297
040 $a MiAaPQD $b eng $c MiAaPQD $e rda
100 1 $a Faucher, Franco Fernando, $e author. $3 3821695
245 1 0 $a Peptide Therapeutics and Diagnostics for Cancer Therapy and Imaging / $c Franco Fernando Faucher.
264 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2024
300 $a 1 electronic resource (441 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 86-05, Section: B.
500 $a Advisors: Bogyo, Matthew Committee members: Banik, Steven; Bertozzi, Carolyn; Bent, Stacey F.
502 $b Ph.D. $c Stanford University $d 2024.
520 $a Peptides have long been part of the drug development pipeline. Therefore, by further exploring the inherent benefits and weaknesses of this modality, we can better design next generation therapeutics and diagnostics. Peptides are generally defined as amino acid polymers comprised of between 2-50 amino acids, making them distinct from small molecules(50 amino acids). Peptides are made of both natural and unnatural amino acid fragments; this modularity has allowed drug designers to generate highly specific therapeutics as many derivatives can be quickly designed to tightly engage the target of interest. Furthermore, the simplicity of their modular design from largely naturally occurring functional groups has allowed drug designers to logically and efficiently modulate properties such as pharmacokinetics, pharmacodynamics, and safety. Due to the natural affinity of peptide like substrates for the active site of proteases, peptides have traditionally been used to target serine hydrolases which play important roles in the pathogenesis of many infectious diseases and cancers. Chapter 1 of this thesis provides a review of recent approaches to use selective covalent inhibitors of serine hydrolases to develop activity-based probes (ABPs). This includes new methodologies that have been designed to improve the potency and specificity of ABPs and to expand their scope and usage as clinically relevant imaging agents. Chapter 2, describes the development of ratiometric activity-based optical contrast agents for image guided surgery. This work addresses many of the current limitations of current clinical contrast agents and demonstrates that peptide-based probes are effective as diagnostic imaging agents. Chapter 3 outlines the use of polymers as scaffolds for improving the in vivoproperties of peptide based imaging contrast agents. These findings provide new insights into the use of polymer-based backbones for enhancing the pharmacodynamic and pharmacokinetic properties of peptide drugs. Chapter 4 outlines a synthesis method for generating diverse covalent cyclic peptides. These peptides are used to identify new druggable targets with the hopes of expanding the druggable proteome. These works, as a collective, are specific applications of peptide-based molecules in the setting of cancer pathologies. Together these works show that peptides can elucidate biological function, such as the case of generating cancer specific fluorescent signals. Furthermore the inhibitor discovery with fluorosulfates shows that peptides can modulate biological systems and can be engineered to create novel functions. Overall, this work provides further evidence for the continued exploration of peptide therapeutics and diagnostics in the context of cancer therapy and imaging.
546 $a English
590 $a School code: 0212
650 4 $a Infections. $3 1621997
650 4 $a Mass spectrometry. $3 551172
650 4 $a Neutrophils. $3 878084
650 4 $a Binding sites. $3 3560349
650 4 $a Labeling. $3 3560710
650 4 $a Design. $3 518875
650 4 $a Amino acids. $3 558768
650 4 $a Scientific imaging. $3 3560377
650 4 $a Chemical bonds. $3 560512
650 4 $a Fluorides. $3 620981
650 4 $a Metabolism. $3 541349
650 4 $a Lipids. $3 558980
650 4 $a Penicillin. $3 3683589
650 4 $a Contrast agents. $3 3681940
650 4 $a Viral infections. $3 3540521
650 4 $a Pathogenesis. $3 3561735
650 4 $a Analytical chemistry. $3 3168300
650 4 $a Medical imaging. $3 3172799
650 4 $a Pathology. $3 643180
650 4 $a Virology. $3 642304
690 $a 0389
690 $a 0486
690 $a 0574
690 $a 0571
690 $a 0720
710 2 $a Stanford University. $e degree granting institution. $3 3765820
720 1 $a Bogyo, Matthew $e degree supervisor.
773 0 $t Dissertations Abstracts International $g 86-05B.
790 $a 0212
791 $a Ph.D.
792 $a 2024
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31643297